The global pharmaceutical filtration market size reached US$ 13.6 Billion in 2023. Looking forward, the market is expected to reach US$ 65.8 Billion by 2032, exhibiting a growth rate (CAGR) of 19.1% during 2023-2032. The escalating demand for biopharmaceuticals, stringent regulatory standards, ongoing technological advancements, and growing focus on drug safety are driving the market growth.
Also, AstraZeneca, a pharmaceutical company, spent more than 23% of its prescription drug earnings in 2023 on research and development. Moreover, the rise in biopharmaceuticals, including monoclonal antibodies and recombinant proteins, requires specialized filtration methods to ensure product quality and yield. These factors are further driving the pharmaceutical filtration market growth.
According to the pharmaceutical filtration market outlook, membrane filters are essential in pharmaceutical manufacturing for processes, such as sterile filtration, virus filtration, and protein purification. They are used in bioprocessing applications for cell culture clarification, concentration, and separation of biomolecules. Moreover, in research laboratories, these are used for sample preparation, microbiological analysis, and particle removal in various scientific experiments.
For instance, in December 2023, TeraPore Technologies, a nanofiltration membranes company, launched IsoBlock VF product line and IsoBlock PF Syringe Prefilter Device for parvovirus elimination from biopharmaceuticals. The IsoBlock PF Syringe Prefilter Device is an adsorptive membrane-based prefilter that removes undesired high-molecular-weight species from the feed prior to size-based virus removal.
As per the pharmaceutical filtration market outlook, microfiltration is commonly used for sterile filtration to remove microorganisms and particles from pharmaceutical solutions and suspensions. This process is critical in preparing sterile drug products, such as injectables, ophthalmic solutions, and parenteral nutrition solutions. Moreover, it is used for clarification and particle removal in pharmaceutical manufacturing processes.
The demand for pharmaceutical filtration in final product processing is critical to ensure the safety, efficacy, and quality of pharmaceutical products before they reach consumers. Moreover, sterile filtration is essential to remove microorganisms and particles from pharmaceutical solutions and suspensions, ensuring they meet stringent sterility requirements. Final drug products, such as injectables (e.g., vaccines, antibiotics), ophthalmic solutions, and other sterile formulations, undergo sterile filtration to eliminate microbiological contaminants.
Pharmaceutical manufacturing operates on large scales to meet global demand for medications. This volume necessitates robust filtration processes to ensure consistent product quality and safety. Moreover, regulatory agencies impose strict guidelines on pharmaceutical manufacturers to ensure product safety, efficacy, and purity. Filtration processes are crucial for meeting these regulatory standards.
According to the pharmaceutical filtration market statistics, the region has a strong presence of biopharmaceutical companies engaged in the production of biologics, vaccines, and biosimilars. For instance, in April 2024, Bavarian Nordic A/S, a fully integrated vaccine company, launched Jynneos, the only FDA-approved mpox vaccine in the United States. This sector requires advanced filtration technologies for processes like sterile filtration, virus filtration, and ultrafiltration/diafiltration (UF/DF). Moreover, continued investments in research and development by pharmaceutical companies and academic institutions fuel innovation in filtration technologies, supporting the market growth.
2. What is the expected growth rate of the global pharmaceutical filtration market during 2024-2032?
3. What are the key factors driving the global pharmaceutical filtration market?
4. What has been the impact of COVID-19 on the global pharmaceutical filtration market?
5. What is the breakup of the global pharmaceutical filtration market based on the product?
6. What is the breakup of the global pharmaceutical filtration market based on the technique?
7. What is the breakup of the global pharmaceutical filtration market based on the application?
8. What is the breakup of the global pharmaceutical filtration market based on the scale of operation?
9. What are the key regions in the global pharmaceutical filtration market?
10. Who are the key players/companies in the global pharmaceutical filtration market?
Pharmaceutical Filtration Market Analysis:
- Major Market Drivers: A considerable rise in the prevalence of chronic diseases coupled with stringent regulations for quality control of drugs has escalated the demand for generic medicines worldwide. Moreover, the rising number of drug launches is positively influencing the adoption of pharmaceutical filtration methods to remove potential pathogens during the manufacturing processes.
- Key Market Trends: Technological advancements in the production of large molecules and biologics along with the rising demand for advanced therapeutic drugs and increasing investments in research and development (R&D) projects are expected to propel the industry's growth. Furthermore, the leading companies are focusing on collaborations, partnerships, and merger and acquisitions (M&A) activities.
- Competitive Landscape: Some of the prominent companies in the market include 3M Company, Amazon Filters Ltd, Danaher Corporation, Eaton Corporation plc, General Electric Company, Graver Technologies LLC, Meissner Filtration Products Inc, Merck KGaA, Parker Hannifin Corporation, and Sartorius AG, among many others.
- Geographical Trends: According to the pharmaceutical filtration market dynamics, North America is dominating the overall market owing to the rising demand for pharmaceutical products driven by the aging population, chronic diseases, and advancements in healthcare infrastructure.
- Challenges and Opportunities: Stringent regulatory requirements and high initial costs associated with pharmaceutical filtration are hampering the market growth. However, the growing biopharmaceuticals and biotechnology sectors create numerous opportunities for specialized filtration solutions capable of handling complex biological substances.
Pharmaceutical Filtration Market Trends:
Rising Spending in Pharmaceutical and Biotechnological Industries
Pharmaceutical companies are investing heavily in research and development, particularly in biotechnology, which requires advanced filtration technologies for processes such as protein purification and cell culture. For instance, according to Statista, large pharmaceutical businesses typically dedicate 20% of their earnings to research and development.Also, AstraZeneca, a pharmaceutical company, spent more than 23% of its prescription drug earnings in 2023 on research and development. Moreover, the rise in biopharmaceuticals, including monoclonal antibodies and recombinant proteins, requires specialized filtration methods to ensure product quality and yield. These factors are further driving the pharmaceutical filtration market growth.
Increasing Demand for Generic Drugs
The increasing demand for generic drugs is one of the prominent factors driving the growth in the pharmaceutical filtration market. For instance, according to the publisher, the global generic drugs market size reached US$ 367.1 Billion in 2023. Looking forward, the market is expected to reach US$ 628.0 Billion by 2032, exhibiting a growth rate (CAGR) of 5.96% during 2024-2032. Generic drugs are manufactured in large volumes to meet global demand, necessitating efficient and scalable filtration processes to ensure quality and regulatory compliance. These factors are further positively influencing the pharmaceutical filtration industry forecast.Growing Prevalence of Chronic Diseases
The increased prevalence of chronic diseases increases the demand for a variety of medications. New medications are introduced to address chronic conditions, such as cancer, diabetes, asthma, COPD, and arthritis. For instance, in December 2023, AstraZeneca Pharma India launched Trastuzumab Deruxtecan, also known as Enhertu, which is used to treat HER2-positive breast cancer. Each new drug launch typically requires scaled-up production to meet the market demand. This increased manufacturing volume directly correlates with higher demand for filtration technologies to ensure product quality and regulatory compliance. These factors are further contributing to the pharmaceutical filtration market share.Global Pharmaceutical Filtration Industry Segmentation:
This report provides an analysis of the key trends in each segment of the global pharmaceutical filtration market report, along with forecasts at the global, regional, and country levels from 2024-2032. The report has categorized the market based on product, technique, application, and scale of operation.Breakup by Product:
- Membrane Filters
- MCE Membrane Filters
- Coated Cellulose Acetate Membrane Filters
- PTFE Membrane Filters
- Nylon Membrane Filters
- PVDF Membrane Filters
- Others
- Prefilters and Depth Media
- Glass Fiber Filters
- PTFE Fiber Filters
- Single-Use Systems
- Cartridges and Capsules
- Filter Holders
- Filtration Accessories
- Others
Membrane filters currently hold the majority of the total market share
The report has provided a detailed breakup and analysis of the pharmaceutical filtration market based on the product. This includes membrane filters (MCE membrane filters, coated cellulose acetate membrane filters, PTFE membrane filters, nylon membrane filters, PVDF membrane filters, and others), prefilters and depth media (glass fiber filters, and PTFE fiber filters), single-use systems, cartridges and capsules, filter holders, filtration accessories, and others. According to the report, membrane filters hold the majority of the total market share.According to the pharmaceutical filtration market outlook, membrane filters are essential in pharmaceutical manufacturing for processes, such as sterile filtration, virus filtration, and protein purification. They are used in bioprocessing applications for cell culture clarification, concentration, and separation of biomolecules. Moreover, in research laboratories, these are used for sample preparation, microbiological analysis, and particle removal in various scientific experiments.
For instance, in December 2023, TeraPore Technologies, a nanofiltration membranes company, launched IsoBlock VF product line and IsoBlock PF Syringe Prefilter Device for parvovirus elimination from biopharmaceuticals. The IsoBlock PF Syringe Prefilter Device is an adsorptive membrane-based prefilter that removes undesired high-molecular-weight species from the feed prior to size-based virus removal.
Breakup by Technique:
- Microfiltration
- Ultrafiltration
- Crossflow Filtration
- Nanofiltration
- Others
Currently, microfiltration exhibits a clear dominance in the market
A detailed breakup and analysis of the pharmaceutical filtration market based on the technique has also been provided in the report. This includes microfiltration, ultrafiltration, crossflow filtration, nanofiltration, and others. According to the report, microfiltration exhibits a clear dominance in the market.As per the pharmaceutical filtration market outlook, microfiltration is commonly used for sterile filtration to remove microorganisms and particles from pharmaceutical solutions and suspensions. This process is critical in preparing sterile drug products, such as injectables, ophthalmic solutions, and parenteral nutrition solutions. Moreover, it is used for clarification and particle removal in pharmaceutical manufacturing processes.
Breakup by Application:
- Final Product Processing
- Active Pharmaceutical Ingredient Filtration
- Sterile Filtration
- Protein Purification
- Vaccines and Antibody Processing
- Formulation and Filling Solutions
- Viral Clearance
- Raw Material Filtration
- Media Buffer
- Pre-Filtration
- Bioburden Testing
- Cell Separation
- Water Purification
- Air Purification
Final product processing currently accounts for the largest market share
The report has provided a detailed breakup and analysis of the pharmaceutical filtration market based on the application. This includes final product processing (active pharmaceutical ingredient filtration, sterile filtration, protein purification, vaccines and antibody processing, formulation and filling solutions, and viral clearance), raw material filtration (media buffer, pre-filtration, and bioburden testing), cell separation, water purification, and air purification. According to the report, final product processing accounts for the largest market share.The demand for pharmaceutical filtration in final product processing is critical to ensure the safety, efficacy, and quality of pharmaceutical products before they reach consumers. Moreover, sterile filtration is essential to remove microorganisms and particles from pharmaceutical solutions and suspensions, ensuring they meet stringent sterility requirements. Final drug products, such as injectables (e.g., vaccines, antibiotics), ophthalmic solutions, and other sterile formulations, undergo sterile filtration to eliminate microbiological contaminants.
Breakup by Scale of Operation:
- Manufacturing Scale
- Pilot-Scale
- Research and Development Scale
Currently, manufacturing scale exhibits a clear dominance in the market
The report has provided a detailed breakup and analysis of the pharmaceutical filtration market based on the scale of operation. This includes manufacturing scale, pilot scale, and research and development scale. According to the report, manufacturing scale exhibits a clear dominance in the market.Pharmaceutical manufacturing operates on large scales to meet global demand for medications. This volume necessitates robust filtration processes to ensure consistent product quality and safety. Moreover, regulatory agencies impose strict guidelines on pharmaceutical manufacturers to ensure product safety, efficacy, and purity. Filtration processes are crucial for meeting these regulatory standards.
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
North America currently dominates the global market
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for pharmaceutical filtration.According to the pharmaceutical filtration market statistics, the region has a strong presence of biopharmaceutical companies engaged in the production of biologics, vaccines, and biosimilars. For instance, in April 2024, Bavarian Nordic A/S, a fully integrated vaccine company, launched Jynneos, the only FDA-approved mpox vaccine in the United States. This sector requires advanced filtration technologies for processes like sterile filtration, virus filtration, and ultrafiltration/diafiltration (UF/DF). Moreover, continued investments in research and development by pharmaceutical companies and academic institutions fuel innovation in filtration technologies, supporting the market growth.
Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global pharmaceutical filtration market. Also, detailed profiles of all major companies have been provided. Some of the companies covered are:- 3M Company
- Amazon Filters Ltd
- Danaher Corporation
- Eaton Corporation plc
- General Electric Company
- Graver Technologies LLC
- Meissner Filtration Products Inc
- Merck KGaA
- Parker Hannifin Corporation
- Sartorius AG
Pharmaceutical Filtration Market Recent Developments:
- June 2024: Cytiva launched its Supor Prime sterilizing grade filters for high-concentration biologic medicines that intends to assist medication developers in increasing yields, reducing blockages, and minimizing cost losses.
- April 2024: Asahi Kasei launched a membrane system for producing WFI (water for injection), a form of sterile water used in injection preparations. The membrane system was created by utilizing the system design and development capabilities of MicrozaTM hollow-fiber membrane for liquid product filtering and water treatment.
- April 2024: Bavarian Nordic A/S, a fully integrated vaccine company, launched Jynneos, the only FDA-approved mpox vaccine in the United States.
Key Questions Answered in This Report
1. How big is the global pharmaceutical filtration market?2. What is the expected growth rate of the global pharmaceutical filtration market during 2024-2032?
3. What are the key factors driving the global pharmaceutical filtration market?
4. What has been the impact of COVID-19 on the global pharmaceutical filtration market?
5. What is the breakup of the global pharmaceutical filtration market based on the product?
6. What is the breakup of the global pharmaceutical filtration market based on the technique?
7. What is the breakup of the global pharmaceutical filtration market based on the application?
8. What is the breakup of the global pharmaceutical filtration market based on the scale of operation?
9. What are the key regions in the global pharmaceutical filtration market?
10. Who are the key players/companies in the global pharmaceutical filtration market?
Table of Contents
1 Preface3 Executive Summary12 Value Chain Analysis14 Price Analysis
2 Scope and Methodology
4 Introduction
5 Global Pharmaceutical Filtration Market
6 Market Breakup by Product
7 Market Breakup by Technique
8 Market Breakup by Application
9 Market Breakup by Scale of Operation
10 Market Breakup by Region
11 SWOT Analysis
13 Porters Five Forces Analysis
15 Competitive Landscape
List of Figures
List of Tables
Companies Mentioned
- 3M Company
- Amazon Filters Ltd
- Danaher Corporation
- Eaton Corporation plc
- General Electric Company
- Graver Technologies LLC
- Meissner Filtration Products Inc
- Merck KGaA
- Parker Hannifin Corporation
- Sartorius AG
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 138 |
| Published | September 2024 |
| Forecast Period | 2023 - 2032 |
| Estimated Market Value ( USD | $ 13.6 Billion |
| Forecasted Market Value ( USD | $ 65.8 Billion |
| Compound Annual Growth Rate | 19.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
